HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-amyloid-beta immunotherapy in Alzheimer's disease: ACC-001 clinical trials are ongoing.

AuthorsJ Michael Ryan, Michael Grundman
JournalJournal of Alzheimer's disease : JAD (J Alzheimers Dis) Vol. 17 Issue 2 Pg. 243 ( 2009) ISSN: 1875-8908 [Electronic] Netherlands
PMID19502708 (Publication Type: Comment, Letter)
Chemical References
  • Amyloid beta-Peptides
  • Antibodies
Topics
  • Alzheimer Disease (therapy)
  • Amyloid beta-Peptides (immunology)
  • Antibodies (therapeutic use)
  • Clinical Trials as Topic
  • Humans
  • Immunotherapy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: